CoJourney Inc

CoJourney Inc. is a global cell and gene therapy CDMO specialising in end-to-end process development, analytical services, and cGMP manufacturing for advanced therapeutics. Founded in 2021, the company supports biotechnology and pharmaceutical innovators developing plasmids, viral vectors, mRNA, sgRNA, and exosome-based therapies for clinical and commercial applications. Their proprietary Zero Chrom® plasmid manufacturing platform delivers high-purity plasmids with improved scalability, reduced contamination risk, faster turnaround times, and significant cost efficiencies compared with traditional chromatography-based approaches. They also provide high-yield viral vector manufacturing platforms and integrated analytical development and QC testing services to accelerate IND-enabling and clinical-stage programmes.

CoJourney Inc. operates state-of-the-art GMP facilities in the United States and China that comply with FDA, EMA, and NMPA standards. Their capabilities span process development, GMP manufacturing, release testing, and regulatory support for cell and gene therapy products. They have supported more than 100 clients globally and delivered hundreds of manufacturing batches across a range of advanced therapy modalities. They focus on enabling faster, more cost-effective development pathways for gene therapy companies by combining manufacturing innovation, regulatory expertise, and scalable production.

quick proposal

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.